This clinical trial is focused on finding the best way to reduce pain in children aged 2 to 17 who have suffered from limb injuries, such as broken arms or legs, and are visiting the emergency department. The study will compare the effectiveness of three different pain relief treatments: intranasal Fentanyl, intranasal Ketamine, and oral Morphine. The main goal is to determine which treatment works best at reducing moderate to severe pain within 30 minutes of administration.
Participants in the study will receive one of the three treatments. Fentanyl and Ketamine will be given through the nose using a special device, while Morphine will be taken by mouth. The study will monitor the children’s pain levels at various times after receiving the medication, specifically at 15, 30, 60, 90, and 120 minutes. The study will also observe any side effects, such as drowsiness, dizziness, or nausea, and assess the overall satisfaction of the children and their parents with the treatment.
The purpose of this study is to improve pain management for children with limb injuries in emergency settings. By comparing these treatments, the study aims to identify the most effective and satisfactory method for reducing pain quickly and safely. The trial is expected to continue until June 2027, with recruitment starting in June 2024.



France